Cargando…
Multiple Myeloma and Diabetes
Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there wil...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262650/ https://www.ncbi.nlm.nih.gov/pubmed/22363889 http://dx.doi.org/10.5402/2011/815013 |
_version_ | 1782221757792387072 |
---|---|
author | Issa, Zeinab A. Zantout, Mira S. Azar, Sami T. |
author_facet | Issa, Zeinab A. Zantout, Mira S. Azar, Sami T. |
author_sort | Issa, Zeinab A. |
collection | PubMed |
description | Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians. |
format | Online Article Text |
id | pubmed-3262650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | International Scholarly Research Network |
record_format | MEDLINE/PubMed |
spelling | pubmed-32626502012-02-23 Multiple Myeloma and Diabetes Issa, Zeinab A. Zantout, Mira S. Azar, Sami T. ISRN Endocrinol Review Article Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians. International Scholarly Research Network 2011 2011-11-17 /pmc/articles/PMC3262650/ /pubmed/22363889 http://dx.doi.org/10.5402/2011/815013 Text en Copyright © 2011 Zeinab A. Issa et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Issa, Zeinab A. Zantout, Mira S. Azar, Sami T. Multiple Myeloma and Diabetes |
title | Multiple Myeloma and Diabetes |
title_full | Multiple Myeloma and Diabetes |
title_fullStr | Multiple Myeloma and Diabetes |
title_full_unstemmed | Multiple Myeloma and Diabetes |
title_short | Multiple Myeloma and Diabetes |
title_sort | multiple myeloma and diabetes |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262650/ https://www.ncbi.nlm.nih.gov/pubmed/22363889 http://dx.doi.org/10.5402/2011/815013 |
work_keys_str_mv | AT issazeinaba multiplemyelomaanddiabetes AT zantoutmiras multiplemyelomaanddiabetes AT azarsamit multiplemyelomaanddiabetes |